Grant Details

General Overview

Grant Information

Grant name: Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)

Funding organization: National Institutes of Health (NIH)

Total funding amount: $400,000 over two years

Primary objective: Support time-sensitive ancillary studies related to ongoing clinical projects

Key stakeholders: Researchers, clinical project participants

Funding source: NIH

Funding type: Grant

Significance: Enhances scientific content and value of parent projects

Grant frequency: Recurring

Organizational Aspects

Eligible Organization Types

Higher Education Institutions

Public/State Controlled Institutions of Higher Education

Private Institutions of Higher Education

Nonprofits Other Than Institutions of Higher Education

For-Profit Organizations

Small Businesses

Local Governments

State Governments

County Governments

City or Township Governments

Indian/Native American Tribal Governments (Federally Recognized)

Indian/Native American Tribal Governments (Other than Federally Recognized)

Ineligibility

Foreign Organizations (non-domestic entities) are not eligible to apply.

Scope and Focus

Primary Focus Areas

Time-sensitive ancillary studies related to NIAMS mission

Studies that address new research questions not covered in parent projects

Technical Details

Technical Expertise Requirements

Applications must demonstrate scientific merit and innovation.

Financial Structure

Budget Limitations

Direct costs limited to $400,000 over two years

No more than $250,000 in direct costs in any single year

Timeline and Implementation

Submission Deadlines

Application due date: December 5, 2025

Compliance and Requirements

Regulatory Compliance

Must comply with NIH Grants Policy Statement.

Application Process

Application Submission

Applications must be submitted electronically through Grants.gov.

Grant Details

healthcare research clinical trials biomedical research NIH funding ancillary studies arthritis musculoskeletal diseases skin diseases
Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
PAR-25-230
NIH Grants
EDU NGO ENTERPRISE PUBLIC RESEARCH
US
HEALTHCARE RESEARCH
DEVELOPMENT
OTHER
SDG3
FUNDING RESEARCH_DEVELOPMENT
None
400000.00
None
400000.00
USD
None
Dec. 5, 2025, 10 p.m.
Not specified